Gemcitabine and docetaxel combination chemotherapy for advanced bone and soft tissue sarcomas: protocol for an open-label, non-randomised, Phase 2 study

Hara, Hitomi; Kawamoto, Teruya; Fukase, Naomasa; Kawakami, Yohei; Takemori, Toshiyuki; Fujiwara, Shuichi; Kitayama, Kazumichi; Nishida, Kotaro; Kuroda, Ryosuke; Akisue, Toshihiro

doi:10.1186/s12885-019-5923-7

BMC Cancer

Article metrics
Last updated: Fri, 26 Apr 2024 19:38:00 Z

Gemcitabine and docetaxel combination chemotherapy for advanced bone and soft tissue sarcomas: protocol for an open-label, non-randomised, Phase 2 study

Access & Citations

23k

Article Accesses
5

Web of Science
6

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com